BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30214448)

  • 1. Suppressor of Cytokine Signaling-1/STAT1 Regulates Renal Inflammation in Mesangial Proliferative Glomerulonephritis Models.
    Bai J; Wu L; Chen X; Wang L; Li Q; Zhang Y; Wu J; Cai G; Chen X
    Front Immunol; 2018; 9():1982. PubMed ID: 30214448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of interferon-gamma signaling by gene transfer of Stat1 mutant in mesangial cells.
    Sakatsume M; Narita I; Yamazaki H; Saito A; Nakagawa Y; Kuriyama H; Kuwano R; Gejyo F; Arakawa M
    Kidney Int; 2000 Feb; 57(2):455-63. PubMed ID: 10652022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts.
    Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R
    J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS1 Peptidomimetic Alleviates Glomerular Inflammation in MsPGN by Inhibiting Macrophage M1 Polarization.
    Zhao Y; Peng F; He J; Qu Y; Ni H; Wu L; Chen X
    Inflammation; 2023 Dec; 46(6):2402-2414. PubMed ID: 37581761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.
    Satou R; Miyata K; Gonzalez-Villalobos RA; Ingelfinger JR; Navar LG; Kobori H
    FASEB J; 2012 May; 26(5):1821-30. PubMed ID: 22302831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1 regulates interferon-γ-induced angiotensinogen and MCP-1 expression in a bidirectional manner in primary cultured mesangial cells.
    Penrose HM; Katsurada A; Miyata K; Urushihara M; Satou R
    J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320946527. PubMed ID: 32741247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
    Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
    Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS1, the feedback regulator of STAT1/3, inhibits the osteogenic differentiation of rat bone marrow mesenchymal stem cells.
    Zhang Y; Jing Z; Cao X; Wei Q; He W; Zhang N; Liu Y; Yuan Q; Zhuang Z; Dong Y; Hong Z; Li J; Li P; Zhang L; Wang H; Li W
    Gene; 2022 May; 821():146190. PubMed ID: 35124149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads.
    Tanaka K; Ichiyama K; Hashimoto M; Yoshida H; Takimoto T; Takaesu G; Torisu T; Hanada T; Yasukawa H; Fukuyama S; Inoue H; Nakanishi Y; Kobayashi T; Yoshimura A
    J Immunol; 2008 Mar; 180(6):3746-56. PubMed ID: 18322180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.
    DiGiandomenico A; Wylezinski LS; Hawiger J
    Sci Signal; 2009 Jul; 2(80):ra37. PubMed ID: 19622834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type.
    Liang YB; Tang H; Chen ZB; Zeng LJ; Wu JG; Yang W; Li ZY; Ma ZF
    Mol Med Rep; 2017 Nov; 16(5):6405-6411. PubMed ID: 28901399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of SOCS1 overexpression on RPE cell activation by proinflammatory cytokines.
    Bazewicz M; Draganova D; Makhoul M; Chtarto A; Elmaleh V; Tenenbaum L; Caspers L; Bruyns C; Willermain F
    Neurosci Lett; 2016 Sep; 630():209-215. PubMed ID: 27478014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.
    Bhattacharyya S; Zhao Y; Kay TW; Muglia LJ
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9554-9. PubMed ID: 21606371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
    Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
    J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
    Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
    Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury.
    Gómez-Guerrero C; López-Franco O; Sanjuán G; Hernández-Vargas P; Suzuki Y; Ortiz-Muñoz G; Blanco J; Egido J
    J Immunol; 2004 Jun; 172(11):6969-77. PubMed ID: 15153517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes.
    Dai X; Sayama K; Yamasaki K; Tohyama M; Shirakata Y; Hanakawa Y; Tokumaru S; Yahata Y; Yang L; Yoshimura A; Hashimoto K
    J Invest Dermatol; 2006 Jul; 126(7):1574-81. PubMed ID: 16628196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glatiramer acetate attenuates the activation of CD4
    Ahn YH; Jeon SB; Chang CY; Goh EA; Kim SS; Kim HJ; Song J; Park EJ
    Sci Rep; 2017 Jan; 7():40484. PubMed ID: 28094337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.